Carlos Iribarren to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Carlos Iribarren has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.402
-
Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort. Cardiovasc Diabetol. 2022 Jul 14; 21(1):132.
Score: 0.176
-
Clinical Utility of Multimarker Genetic Risk Scores for Prediction of Incident Coronary Heart Disease: A Cohort Study Among Over 51 Thousand Individuals of European Ancestry. Circ Cardiovasc Genet. 2016 Dec; 9(6):531-540.
Score: 0.118
-
Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006 Feb 21; 144(4):229-38.
Score: 0.057
-
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
Score: 0.051